Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial

Divya Mohan, Holly R. Keir, Hollian Richardson, David Mayhew, Joseph Boyer, Marc P. van der Schee, Max D. Allsworth, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers
ERJ Open Research 2021 7: 00253-2021; DOI: 10.1183/23120541.00253-2021
Divya Mohan
1GSK R&D, Collegeville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Divya Mohan
Holly R. Keir
2Ninewells Clinical Research Centre, University of Dundee, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hollian Richardson
2Ninewells Clinical Research Centre, University of Dundee, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Mayhew
1GSK R&D, Collegeville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Boyer
1GSK R&D, Collegeville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc P. van der Schee
3Owlstone Medical, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max D. Allsworth
3Owlstone Medical, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce E. Miller
1GSK R&D, Collegeville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruce E. Miller
Ruth Tal-Singer
1GSK R&D, Collegeville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ruth Tal-Singer
James D. Chalmers
2Ninewells Clinical Research Centre, University of Dundee, Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.chalmers@dundee.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 4
DOI 
https://doi.org/10.1183/23120541.00253-2021

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received April 11, 2021
  • Accepted July 19, 2021
  • Published online October 4, 2021.

Article Versions

  • previous version (August 26, 2021 - 07:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Divya Mohan1,
  2. Holly R. Keir2,
  3. Hollian Richardson2,
  4. David Mayhew1,
  5. Joseph Boyer1,
  6. Marc P. van der Schee3,
  7. Max D. Allsworth3,
  8. Bruce E. Miller1,
  9. Ruth Tal-Singer1 and
  10. James D. Chalmers2⇑
  1. 1GSK R&D, Collegeville, PA, USA
  2. 2Ninewells Clinical Research Centre, University of Dundee, Dundee, UK
  3. 3Owlstone Medical, Cambridge, UK
  1. Corresponding author: James D. Chalmers (j.chalmers{at}dundee.ac.uk)
View Full Text

Funding

  • GlaxoSmithKline

    GSK study 207551

Article usage

Article usage: August 2021 to September 2023

AbstractFullPdf
Aug 202118285
Sep 20215129101
Oct 202129471108
Nov 20211133178
Dec 20211314350
Jan 2022710742
Feb 2022144231
Mar 202296142
Apr 202255847
May 202265237
Jun 2022253924
Jul 202245729
Aug 202294826
Sep 202298447
Oct 202247728
Nov 202273219
Dec 202221613
Jan 202383519
Feb 202312811
Mar 20234137
Apr 20231610
May 2023101821
Jun 202372613
Jul 202333017
Aug 20233148
Sep 202332020

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 4 Table of Contents
ERJ Open Research: 7 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
Divya Mohan, Holly R. Keir, Hollian Richardson, David Mayhew, Joseph Boyer, Marc P. van der Schee, Max D. Allsworth, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers
ERJ Open Research Oct 2021, 7 (4) 00253-2021; DOI: 10.1183/23120541.00253-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
Divya Mohan, Holly R. Keir, Hollian Richardson, David Mayhew, Joseph Boyer, Marc P. van der Schee, Max D. Allsworth, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers
ERJ Open Research Oct 2021, 7 (4) 00253-2021; DOI: 10.1183/23120541.00253-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original research articles

  • Effects of IMT on exertional breathlessness in UDD
  • 6MWT to assess response to therapy in severe asthma
  • Endogenous steroids in asthma
Show more Original research articles

COPD

  • Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
  • Effects of PA interventions in COPD
  • Laboratory and free-living gait performance in COPD
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society